The Allegheny Health Network-Johns Hopkins collaboration is expanding to include greater clinical and research initiatives, as well as group purchasing deals and other efficiencies, the two parties announced Monday.
And there may be more to come.
“There is genuine interest on both sides to grow that relationship further into other clinical services” beyond the oncology partnership agreement reached last January, said AHN Chief Medical Officer Tony Farah in a media phone briefing Monday morning.
“I anticipate we will be working on a number of other fronts clinically,” including appointing some AHN physicians to Hopkins and trainee exchanges at both institutions.
Monday’s announcement brings AHN, parent Highmark Health, and Johns Hopkins Medicine together on initiatives that officials say will improve access and add options for affordable care, as well as allow AHN to tap into the Hopkins’ Armstrong Institute for Patient Safety and Quality. The two organizations will collaborate on new electronic medical record platforms, as well as various research and educational initiatives.
The 10-year agreement does not involve any exchange of money.
“This collaboration is about two healthcare organizations coming together in a unique strategic relationship to advance quality, access and affordability of healthcare and drive innovations — clinically, operationally and from a product perspective — that will change the future of medicine for the better,” said John Paul, AHN president and CEO.
Mr. Paul said a number of initiatives already are underway, such as developing new medical software and new payment schemes, from which AHN expects to see more than $6 million in savings.
In a statement, Brian Gragnolati, senior vice president for the Johns Hopkins Health System, said in the ever-changing health care environment, “It makes sense to find synergies with other entities with similar missions and different strengths.”
“Our goal is to ensure that patients have affordable access to high-quality health care services,” said Highmark Health President and CEO David Holmberg, “and the increased collaboration we anticipate with Johns Hopkins through this agreement is an important step in the fulfillment of that mission.”
Dr. Farah said that while he expects the collaboration with Hopkins to continue to grow, “the vast majority” of Pittsburgh patients will continued to be treated locally rather than traveling to the Baltimore-based center.
But he added that a number of patients here have already benefitted from consultations with Hopkins staff and some early phase clinical trials.
Steve Twedt: stwedt@post-gazette.com or 412-263-1963. Bill Toland: btoland@post-gazette.com or 412-263-2625.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.